Linked Life Data

10392078

Source:http://linkedlifedata.com/resource/pubmed/id/10392078

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-7-8
pubmed:abstractText
Haemodialysis patients are at high risk of developing liver disease due to blood-borne viral agents. At present hepatitis C virus (HCV) is the most common cause of infection in these patients. A new RNA virus of the Flaviviridae family, hepatitis G virus (HGV) has recently been cloned. HGV prevalence in haemodialysis patients ranges from 3.1% to 57.5%. The aim of this study has been to detect HGV-RNA in our haemodialysis patients in order to evaluate the prevalence of HGV and to correlate the viral presence to liver disease. A total of 79 patients, on haemodialysis for a mean of 52 months, were tested. 3 patients (3.8%) were HBsAG positive and 19 patients (24%) were HCV positive. 24 of the 79 (30%) patients had been transfused. Only 2 of the 79 patients (2.5%) were HGV positive. These patients were HBsAG and anti HCV negative, both had been previously transfused and showed no signs of liver disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
N
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1019-083X
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
Is hepatitis G virus a real risk for haemodialysis patients?
pubmed:affiliation
Department of Internal Medicine, University of Genoa, Italy.
pubmed:publicationType
Journal Article